This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Feb 2011

Elan Signs Global Development Pact with PPD

Elan has announced an agreement with contract research company PPD to drive clinical programs globally.

Elan and PPD, Inc. have entered a global business collaboration to facilitate the development of Elan’s portfolio. The purpose of the alliance is to leverage both companies’ expertise in a flexible, integrated manner to advance Elan’s clinical programs globally.

PPD will serve as Elan’s primary service provider for all development functions and activities. Elan will retain ownership of its assets and will be responsible for all decisions regarding strategy and progression of candidates, as well as the overall portfolio. Elan will leverage PPD’s capabilities across project and data management, biostatistics, regulatory, clinical and medical monitoring, quality assurance, pharmacovigilance and other areas. The two companies will work together to build upon this initial relationship

Related News